ADHD

Gambling

Opioid Related Disorders

Alcohol Abuse

Amphetamine Related Disorders

Substance Use Disorder

Addiction & Substance Use

Alzheimer Disease

Disaster Psychiatry

Panic Disorder

Trauma And Violence

Traumatic Stress Disorders

Anxiety & Stress Disorders

Mania

Bipolar Disorder

COVID-19

Cannabis

Case Discussions

Child & Adolescent Psychiatry

Climate Change

Comorbidity

Compulsive Disorders

Cultural Psychiatry

Digital Therapeutics

Diversity, Equity, Inclusion

Drug Watch

Eating Disorders

Emergency Psychiatry

Ethics

Munchausen Syndrome

Sexual Offenses

Forensic Psychiatry

Geriatric Psychiatry

Integrative Psychiatry

Major Depressive Disorder

Media & Psychiatry

Mental Health Awareness Month

Mood Disorders

Cognitive Disorders

Dementia

Autism

Neuropsychiatry

PTSD

Compulsive Personality Disorder

Dependent Personality Disorder

Dissociative Identity Disorder

Histrionic Personality Disorder

Schizoid Personality Disorder

Antisocial Personality Disorder

Borderline Personality

Personality Disorders

Postpartum Depression

Psychedelics

Psychopharmacology

Delirium

Metabolic Disorders

Somatoform Disorder

Psychosomatics

Cognitive Behavioral Therapy

Psychotherapy

Paranoid Schizophrenia

Psychotic Affective Disorders

Schizoaffective

Schizophrenia Psychotic Features

Schizotypal Personality Disorder

Catatonic Schizophrenia

Schizophrenia/Psychosis

Nocturnal Paroxysmal Dystonia

Sleep Deprivation

Sleep Wake Transition

Circadian Rhythm Sleep Disorders

Sleep Disorders

Pervasive Developmental Disorder

Gender Issues

Military Mental Health

Special Populations

Sports Psychiatry

Suicide

Tardive Dyskinesia

Technology & Psychiatry

Transcranial Magnetic Stimulation

News

Media

Peer Exchange

Case-Based Psych Perspectives

Clinical Case Collective

Insights

Peers & Perspectives

Slideshows

Videos

Conferences

Conference Coverage

Conference Listing

Publication

Psychiatric Times

Job Board

CME/CE

Partners

Editorial

Resources

Between the Lines

Expert Perspectives

Clinical Consult

Clinical Scales

Interactive Tools

Partner Perspectives

Quizzes

Series

Special Reports

Subscribe

Articles

Alto Neuroscience's ALTO-203 trial reveals mixed results, highlighting potential biomarkers for targeted depression treatment despite missing primary efficacy goals.

ALTO-203 Fails to Primary Efficacy Endpoint in Phase 2 Major Depressive Disorder Trial

is an award-winning psychiatrist who specialized in the cultural and ethical aspects of psychiatry and is now in retirement and retirement as a private pro bono community psychiatrist. A prolific writer and speaker, he has done a weekday column titled “Psychiatric Views on the Daily News” and a weekly video, “Psychiatry & Society,” since the COVID-19 pandemic emerged. He was chosen to receive the 2024 Abraham Halpern Humanitarian Award from the American Association for Social Psychiatry. Previously, he received the Administrative Award in 2016 from the American Psychiatric Association, the one-time designation of being a Hero of Public Psychiatry from the Speaker of the Assembly of the APA in 2002, and the Exemplary Psychiatrist Award from the National Alliance for the Mentally Ill in 1991. He presented the third Rabbi Jeffrey B. Stiffman lecture at Congregation Shaare Emeth in St. Louis on Sunday, May 19, 2024. He is an advocate and activist for mental health issues related to climate instability, physician burnout, and xenophobia. He is now editing the final book in a 4-volume series on religions and psychiatry for Springer: Islamophobia, anti-Semitism, Christianity, and now

 The Eastern Religions, and Spirituality

Explore the intriguing connections between afterlife beliefs, personal experiences, and the psychological impact of grief in this thought-provoking analysis.

The Afterlife and Psychiatry

Researchers uncover a novel biomarker for major depressive disorder, linking regional homogeneity in fMRI to decreased cerebral blood flow and symptom severity.

Functional vs Structural Cortical Deficit Pattern Biomarkers for Major Depressive Disorder

Augmented reality can transform psychiatric treatment, enhancing exposure therapy for trauma and anxiety by simulating real-world environments and interactions.

AI and Augmented Reality: A Transdiagnostic Tool for Real-World Function

Psychiatric Times is the connection to Psychiatry and Mental Health, featuring clinical updates, expert views, and research news in multimedia formats.

About

Advertise

Contact Us

Terms and Conditions

Privacy Policy

Do Not Sell My Personal Information

Psychiatric Times - Mental Health News, Clinical Insights

Facebook

LinkedIn

Spotlight

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia

Commentary

Couch In Crisis

Early Career Psychiatry

History of Psychiatry

Residents Corner

Cultural Corner

Film and Book Reviews

Poetry

Writers Contest

Psychiatric Practice

Burnout

Careers

Coding

Guidelines

Risk Management

Telepsychiatry

Critical Conversations in Psychiatry

Portraits

Psychiatric Views on the Daily News

Tales from the New Asylum

Case Based Psych Perspectives

 video interviews feature a key opinion leader highlighting patient case within a therapeutic area. This peer-to-peer, case-based format examines specific patient populations and the risks associated with symptom management, treatment paradigms, and adverse effect management.

1rem

Panelists discuss personalized treatment strategies for adult patients with narcolepsy, using clinical case examples to highlight common prescribing challenges and emphasizing practical approaches to improve treatment adherence and optimize long-term outcomes.

Optimizing Narcolepsy Management in Adult Patients